МІКРОБІОТА ОРГАНІЗМУ ЛЮДИНИ ТА РАК ГРУДНОЇ ЗАЛОЗИ
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17855Ключові слова:
рак грудної залози, мікробіота.Анотація
Злоякісні новоутворення грудної залози за статистикою в світі випереджають усі пухлинні захворювання у жінок. Нині вже багато відомо щодо молекулярних підтипів цих злоякісних новоутворень, механізмів розвитку лікарської стійкості. Значного успіху досягнено в підходах до ранньої діагностики, що дозволяє визначити пухлинний процес на ранніх стадіях розвитку. Останнім часом активно розвивається галузь досліджень щодо впливу мікробіоти організму людини на розвиток та ефективність лікування пацієнтів з пухлинними захворюваннями, у тому числі і злоякісних новоутворень грудної залози. У цьому огляді представлено аналіз даних літератури з цього питання.
Посилання
The Integrative HMP (iHMP) Research Network Consortium The Integrative Human Microbiome Project. Nature 2019; 569: 641–49. https://doi.org/10.1038/s41586-019-1238-8
Plichta DR, Juncker AS, Bertalan M, et al. Transcriptional interactions suggest niche segregation among microorganisms in the human gut. Nat Microbiol 2016; 1: 1–6. https://doi.org/10.1038/nmicrobiol.2016.152
Lloyd-Price J, Mahurkar A, Rahnavard G, et al. Strains, functions and dynamics in the expanded Human Microbiome Project. Nature 2017; 550: 61–87. https://doi.org/10.1038/nature23889
Visconti A, Le Roy C, Rosa F, et al. Interplay between the human gut microbiome and host metabolism. Nat Commun 2019; 10: 1–10. https://doi.org/10.1038/s41467-019-12476-z
Yadav M, Verma MK, Chauhan NS. A review of metabolic potential of human gut microbiome in human nutrition. Arch Microbiol 2017; 200: 1–15. https://doi.org/10.007/s00203-017-1459-x
Cong J, Zhang X. How human microbiome talks to health and disease. Eur J Clin Microbiol Infect Dis 2018; 37: 1–7. https://doi.org/10.1007/s10096-0183263-1
Schroeder BO, Bäckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med 2016; 22: 1079–90. https://doi.org/10.1038/nm.4185
Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet 2012; 13: 260–71. https://doi.org/10.1038/nrg3182
Olive AJ, Sassetti CM. Metabolic crosstalk between host and pathogen: sensing, adapting and competing. Nat Rev Microb 2016; 14: 1–16. https://doi.org/10.1038/nrmicro.2016.12
Dzutsev A, Badger JH, Perez-Chanona E, et al. Microbes and cancer. Annu Rev Immunol 2017; 35: 99–228. https://doi.org/10.1146/annurev-immunol-051116-052133
Eyvazia S, Vostakolaeic MA, Dilmaghanid A, et al. The oncogenic roles of bacterial infections in development of cancer. Microb Pathog 2020; 141: 1–10. https://doi.org/10.1016/j.micpath.2020.104019
Roesler BM, Rabelo-Gonзalves EMA, Zeitune JMR. Helicobacter pylori and upper gastrointestinal diseases: a review. Health 2014; 6: 263–73. https://doi.org/10.4236/health.2014.64039
Wu J, Li Q, Fu X. Fusobacterium nucleatum contributes to the carcinogenesis of colorectal cancer by inducing inflammation and suppressing host immunity. Transl Oncol 2019; 12: 846–85. https://doi.org/10.1016/j.tranon.2019.03.003
Timbang MR, Sim MW, Bewley AF, et al. HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection. Hum Vaccin Immunother 2019; 15: 1920–8. https://doi.org/10.1080/21645515.2019.1600985
Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: one case — two diseases. Cancer 2017; 123: 2219–29. https://doi.org/10.1002/cncr.30588
Aykut B, Pushalkar S, Chen R, et al. The fungal mycobiome promotes pancreatic oncogenesis via MBL activation. Nature 2019; 574: 264–7. https://doi.org/10.1038/s41586-019-1608-2
Nejman D, Livyatan I, Fuks G, et al. The human tumor microbiome is composed of tumor type–specific intracellular bacteria. Science 2020; 368: 973–80. https://doi.org/10.1126/science.aay9189
Chekhun VF, Lukyanova NYu, Shvets YuV. Impact of microibiota on development of tumors in human. Onkologiya 2020; 22: 1–9 (in Ukrainian). https://doi.org/10.32471/oncology.2663-7928.t- 22-1-2020-g.8759
Shvets YuV, Lukyanova NYu, Chekhun VF. Human microbiota and effectiveness of cancer chemotherapy. Exp Oncol 2020; 42: 1–12. https://doi.org/10.32471/ exp-oncology.2312-8852.vol-42-no-2.14611
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 1–41. https://doi.org/10.3322/caac.21660
Ahmad A. Breast cancer statistics: recent trends. In: Breast Cancer Metastasis and Drug Resistance. Ahmad A, ed. Second Edition, Springer Nature Switzerland AG, 2019: 1–8.
Wendt C, Margolin S. Identifying breast cancer susceptibility genes — a review of the genetic background in familial breast cancer. Acta Oncol 2019; 58: 135–46. https://doi.org/10.1080/0284186X.2018.1529428
Park HL. Epigenetic biomarkers for environmental exposures and personalized breast cancer prevention. Int J Environ Res Public Health 2020; 17: 1–18. https://doi.org/10.3390/ijerph17041181
Alizadeh M, Shojaeifarb S, Nedaeiniac R, et al. Association between the microbiota and women’s cancers — Cause or consequences? Biomed Pharmacother 2020; 127: 110203. https://doi.org/10.1016/j.biopha.2020.110203
Younes JA, Lievens E, Hummelen R, et al. Women and their microbes: the unexpected friendship. Trends Microbiol 2018; 26: 16–33. https://doi.org/10.1016/j.tim.2017.07.008
Hieken TJ, Chen J, Hoskin TL, et al. The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci Rep 2016; 6: 1–10. https://doi.org/10.1038/srep30751
Costantini L, Magno S, Albanese D, et al. Characterization of human breast tissue microbiota from core needle biopsies through the analysis of multi hypervariable 16S-rRNA gene regions. Sci Rep 2018; 8: 1–9. https://doi.org/10.1038/s41598-018-35329-z
Klann K, Williamson JM, Tagliamonte MS, et al. Microbiota composition in bilateral healthy breast tissue and breast tumors. Cancer Causes Control 2020; 31: 1–12. https://doi.org/10.1007/s10552-020-01338-5
Togo А, Dufour J, Lagier J, et al. Repertoire of human breast and milk microbiota: a systematic review. Future Microbiol 2019; 14: 623–41. https://doi.org/10.2217/fmb-2018-0317
Ojo-Okunola A, Nicol M, du Toit E. Human breast milk bacteriome in health and disease. Nutrients 2018; 10: 1–13. https://doi.org/10.3390/nu10111643
Jost T, Lacroix C, Braegger CP. Vertical mother-neonate transfer of maternal gut bacteria via breastfeeding. Environ Microbiol 2014; 16: 2891–904. https://doi.org/10.1111/1462-2920.12238
Katríona E, Lyons KE, Ryan CA, et al. Breast milk, a source of beneficial microbes and associated benefits for infant health. Nutrients 2020; 12: 1–30. https://doi.org/10.3390/nu12041039
Unar-Munguía M, Torres-Mejía G, Colchero MA, et al. Breastfeeding mode and risk of breast cancer: a dose-response meta-analysis. J Hum Lact 2017; 33: 422–34. https://doi.org/10.1177/0890334416683676
Johnson HM, Mitchell KB. Breastfeeding and breast cancer: managing lactation in survivors and women with a new diagnosis. Ann Surg Oncol 2019; 26: 3032–9. https://doi.org/10.1245/s10434-019-07596-1
Stinson LF, Sindi ASM, Cheema AS, et al. The human milk microbiome: who, what, when, where, why, and how? Nutr Rev 2021; 79: 1–18. https://doi.org/10.1093/nutrit/nuaa029
Greer FR. Origins of the human milk microbiome: a complex issue. J Nutr 2019; 149: 1–3. https://doi.org/10.1093/jn/nxz004
de Andrés J, Jiménez E, Chico-Calero I, et al. Physiological translocation of lactic acid bacteria during pregnancy contributes to the composition of the milk microbiota in mice. Nutrients 2018; 10: 14. https://doi.org/10.3390/nu10010014
Arroyo R, Martin V, Maldonado A, et al. Treatment of infectious mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clin Infect Dis 2010; 50: 1551–8. https://doi.org/10.1086/652763
Picardoa SL, Coburnb B, Hansen AR, et al. The microbiome and cancer for clinicians. Crit Rev Oncol Hematol 2019; 141: 1–12. https://doi.org/10.1016/j.critrevonc.2019.06.004
Hieken TJ, Chen J, Hoskin TL, et al. The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci Rep 2016; 6: 1–10. https://doi.org/10.1038/srep30751
Urbaniak C, Cummins J, Brackstone M, et al. Microbiota of human breast tissue. Appl Environ Microbiol 2014; 80: 3007–14. https://doi.org/10.1128/AEM.00242-14
Thyagarajan S, Zhang Y, Thapa S, et al. Comparative analysis of racial differences in breast tumor Microbiome. Sci Rep 2020; 10: 1–13. https://doi.org/10.1038/s41598-020-71102-x
Urbaniak C, Gloor GB, Brackstone M, et al. The microbiota of breast tissue and its association with breast cancer. Appl Environ Microbiol 2016; 82: 5039–49. https://doi.org/10.1128/AEM.01235-16
Xuan C, Shamonki JS, Chung A, et al. Microbial dysbiosis is associated with human breast cancer. PLoS One 2014; 9: 1–7. https://doi.org/10.1371/journal.pone.0083744
Komorowski AS, Pezo RC. Untapped “-omics”: the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment. Breast Cancer Res Treat 2019; 179: 1–19. https://doi.org/10.1007/s10549-019-05472-w
Banerjee S, Wei Z, Tan F, et al. Distinct microbiological signatures associated with triple negative breast cancer. Sci Rep 2015; 5: 15162. https://doi.org/10.1038/srep15162
Banerjee S, Tian T, Wei Z, et al. Distinct microbial signatures associated with different breast cancer types. Front Microbiol 2018; 9: 951. https://doi.org/10.3389/fmicb.2018.00951
Wang H, Altemus J, Niazi F, et al. Breast tissue, oral and urinary microbiomes in breast cancer. Oncotarget 2017; 8: 88122–38. https://doi.org/10.18632/oncotarget.21490
Vaiserman A, Romanenko M, Piven L, et al. Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population. BMC Microbiol 2020; 20: 1–8. https://doi.org/10.1186/s12866-020-01903-7
Du J, Zhou N, Liu H, et al. Arsenic induces functional re-expression of estrogen receptor a by demethylation of DNA in estrogen receptor-negative human breast cancer. PLoS One 2012; 7: 1–10. https://doi.org/10.1371/journal.pone.0035957
Karihtala P, Kauppila S, Soini Y, et al. Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas. BMC Cancer 2011; 11: 1–6. https://doi.org/10.1186/1471-2407-11-262
Mani S. Microbiota and breast cancer. Prog Mol Biol Transl Sci 2017; 151: 217–30. https://doi.org/10.1016/bs.pmbts.2017.07.004
Saggioro А. Leaky gut, microbiota, and cancer an incoming hypothesis. J Clin Gastroenterol 2014; 48: 1–5. https://doi.org/10.1097/MCG.0000000000000255
Magne F, Gotteland M, Gauthier L, et al. The Firmicutes/Bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients 2020; 12: 1–12. https://doi.org/10.3390/nu12051474
Gunter MJ, Xie XH, Xue XN, et al. Breast cancer risk in metabolically healthy but overweight postmenopausal women. Cancer Res 2015; 75: 270–4. https://doi.org/10.1158/0008-5472.CAN-14-2317
Yang J, Tan Q, Fu Q, et al. Gastrointestinal microbiome and breast cancer: correlations, mechanisms and potential clinical implications. Breast Cancer 2016; 24: 1–9. https://doi.org/10.1007/s12282-016-0734-z
Fernández MF, Reina-Pérez I, Astorga JM, et al. Breast cancer and its relationship with the microbiota. Int J Environ Res Public Health 2018; 15: 1–20. https://doi.org/10.3390/ijerph15081747
Goedert JJ, Jones G, Hua X, et al. Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. J Natl Cancer Inst 2015; 107: 1–5. https://doi.org/10.1093/jnci/djv147
Zhu J, Liao M, Yao Z, et al. Breast cancer in postmenopausal women is associated with an altered gut metagenome. Microbiome 2018; 6: 1–13. https://doi.org/10.1186/s40168-018-0515-3
Arumugam M, Raes J, Pelletier E, et al. MetaHIT Consortium, Enterotypes of the human gut microbiome. Nature 2011; 473: 174–80. https://doi.org/10.1038/nature09944
Luu TH, Michel C, Bard JM, et al. Intestinal proportion of Blautia sp. is associated with clinical stage and histoprognostic grade in patients with early-stage breast cancer. Nutr Cancer 2017; 69: 1–9. https://doi.org/10.1080/01635581.2017.1263750
Baker JM, Al-Nakkashc L, Herbst-Kralovetz MM. Estrogen–gut microbiome axis: Physiological and clinical implications. Maturitas 2017; 103: 45–53. https://doi.org/10.1016/j.maturitas.2017.06.025
Zhao H, Yu Z, Zhao L, et al. HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy. Jpn J Clin Oncol 2016; 46: 893–902. https://doi.org/10.1093/jjco/hyw096
Liu H, Wang J, He T, et al. Butyrate: a double-edged sword for health? Adv Nutr 2018; 9: 21–9. https://doi.org/10.1093/advances/nmx009
Damaskos C, Valsami S, Konto M, et al. Histone deacetylase inhibitors: an attractive therapeutic strategy against breast cancer. Anticancer Res 2017; 37: 35–46. https://doi.org/10.21873/anticanres.11286
Biagioli M, Carino A. Signaling from intestine to the host: how bile acids regulate intestinal and liver immunity. Handb Exp Pharmacol 2019; 256: 1–14. https://doi.org/10.1007/164_2019_225
Funabashi M, Grove TL, Wang M, et al. A metabolic pathway for bile acid dehydroxylation by the gut microbiome. Nature 2020; 582: 566–70. https://doi.org/10.1038/s41586-020-2396-4
Chen ML, Takeda K, Sundrud MS. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol 2019; 12: 851–61. https://doi.org/10.1038/s41385-019-0162-4
Fiorucci S, Biagioli M, Zampella A, et al. Bile acids activated receptors regulate innate immunity. Front Immunol 2018; 9: 1–17. https://doi.org/10.3389/fimmu.2018.01853
Costarelli V, Sanders TA. Plasma deoxycholic acid concentration is elevated in postmenopausal women with newly diagnosed breast cancer. Eur J Clin Nutr 2002; 56: 925–7. https://doi.org/10.1038/sj.ejcn.1601396
Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013; 499: 97–101. https://doi.org/10.1038/nature12347
Alasmael N, Mohan R, Meira LB, et al. Activation of the Farnesoid X-receptor in breast cancer cell lines results in cytotoxicity but not increased migration potential. Cancer Lett 2016; 370: 250–9. https://doi.org/10.1016/j.canlet.2015.10.031
Plaza-Díaz J, Álvarez-Mercado AI, Ruiz-Marín CM, et al. Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical study. BMC Cancer 2019; 19: 1–9. https://doi.org/10.1186/s12885-019-5660-y
Sheetal S, Sharma D. The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer. Biochim Biophis Acta Rev Cancer 2019; 1871: 392–405. https://doi.org/10.1016/j.bbcan.2019.04.001
Rao VP, Poutahidis T, Ge ZM, et al. Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res 2006; 66: 7395–400. https://doi.org/10.1158/0008-5472.CAN-06-0558
Rosean CB, Bostic RR, Ferey JCM, et al. Pre-existing commensal dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in hormone receptor-positive breast cancer. Cancer Res 2019; 79: 3662–75. https://doi.org/10.1158/0008-5472.CAN-18-3464
Laborda-Illanes A, Sanchez-Alcoholado L, Dominguez-Recio ME, et al. Breast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment. Cancers 2020; 12: 1–27. https://doi.org/10.3390/cancers12092465
Chen KL, Madak-Erdogan Z. Estrogen and microbiota crosstalk: Should we pay attention? Trends Endocrinol Metab 2016; 27: 752–5. https://doi.org/10.1016/j.tem.2016.08.001
Fuentes N, Silveyra P. Estrogen receptor signaling mechanisms. Adv Protein Chem Struct Biol 2019; 116: 135–70. https://doi.org/10.1016/bs.apcsb.2019.01.001
Grandi G, del Savo MC, da Silva-Filho AL, et al. Estetrol (E4): the new estrogenic component of combined oral contraceptives. Expert Rev Clin Pharmacol 2020 13: 327–30. https://doi.org/10.1080/17512433.2020.1750365
Hamilton KJ, Hewitt CS, Arao Y, et al. Estrogen hormone biology. Curr Top Dev Biol 2017; 125: 109–46. https://doi.org/10.1016/bs.ctdb.2016.12.005
Kwa M, Plottel CS, Martin J, et al. The intestinal microbiome and estrogen receptor–positive female breast cancer. J Natl Cancer Inst 2016; 108: 1–10. https://doi.org/10.1093/jnci/djw029
Chen KL, Madak-Erdogan Z. Estrogen and microbiota crosstalk: should we pay attention? Trends Endocrinol Metab 2016; 27: 1–4. https://doi.org/10.1016/j.tem.2016.08.001
Parida S, Sharma D. The microbiome–estrogen connection and breast cancer risk. Cells 2019; 8: 1–19. https://doi.org/10.3390/cells8121642
Plottel CS, Blaser MJ. Microbiome and malignancy. Cell Host Microbe 2011; 10: 324–35. https://doi.org/10.1016/j.chom.2011.10.003
Raftogianis R, Creveling C, Weinshilboum R, et al. Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr 2000; 27: 113–24. https://doi.org/10.1093/ oxfordjournals.jncimonographs.a024234
Ervin SM, Li H, Lim L, et al. Redinbо. Gut microbiome–derived β-glucuronidases are components of the estrobolome that reactivate estrogens. J Biol Chem 2019; 294: 18586–99. https://doi.org/10.1074/jbc.RA119.010950
Godoy-Vitorino F. Human microbial ecology and the rising new medicine. Ann Transl Med 2019; 7: 1–9. https://doi.org/10.21037/atm.2019.06.56
Fuhrman BJ, Feigelson HS, Flores R, et al. Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. J Clin Endocrinol Metab 2014; 99: 1–9. https://doi.org/10.1210/jc.2014-2222
Adlercreutz Н. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990; 201: 3–23.
Hill MI, Drasar BS, Aries V, et al. Bacteria and aetiology of cancer of large bowel. Gut 1969; 10: 334–5. https://doi.org/10.1136/gut.10.5.334
Newman TM, Mara Z, Vitolins MZ, et al. From the table to the tumor: the role of Mediterranean and Western dietary patterns in shifting microbial-mediated signaling to impact breast cancer risk. Nutrients 2019; 11: 1–15. https://doi.org/10.3390/nu11112565
Griffiths K, Aggarwal BB, Singh RB, et al. Food antioxidants and their anti-inflammatory properties: a potential role in cardiovascular diseases and cancer prevention. Diseases 2016; 4: 1–15. https://doi.org/10.3390/diseases4030028
Shively CA, Register TC, Appt SE, et al. Consumption of Mediterranean versus Western diet leads to distinct mammary gland microbiome populations. Cell Rep 2018; 25: 47–56. https://doi.org/10.1016/j.celrep.2018.08.078
Schirmer M, Smeekens SP, Vlamakis H, et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 2016; 167: 1125–36. https://doi.org/10.1016/j.cell.2016.10.020
Sender R, Fuchs S, Milo R. Are we really wastly outnumbered? revisiting the ratio of bacterial to host cells in humans. Cell 2016; 164: 337–40. https://doi.org/10.1016/j.cell.2016.01.013
Baker JM, Chase DM, Herbst-Kralovetz MM. uterine microbiota: residents, tourists, or invaders? Front Immunol 2018; 9: 1–12. https://doi.org/10.3389/fimmu.2018.00208
Ploton MC, Abakka S, Amouyal E, et al. The lung microbiota. Arch Pediatr 2017; 24: 667–74. https://doi.org/10.1016/ j.arcped.2017.04.007
Dhar D, Mohanty A. Gut microbiota and Covid-19 — possible link and implications. Virus Res 2020; 285: 198018. https://doi.org/10.1016/j.virusres.2020.198018
He Y, Wang J, Li F, et al. Main clinical features of COVID-19 and potential prognostic and therapeutic value of the microbiota in SARS-CoV-2 infections. Front Microbiol 2020; 11: 1302. https://doi.org/10.3389/fmicb.2020.01302
Yeoh YK, Zuo T, Chung-Yan-Lui G, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 2021; 70: 698–706. https://doi.org/10.1136/gutjnl-2020-323020
Dai M, Liu D, Liu M et al. Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov 2020; 10: 783–91. https://doi.org/10.1158/2159-8290.CD-20-0422
Lasagna A, Zuccaro V, Ferraris E, et al. COVID-19 and breast cancer: may the microbiome be the issue? Future Oncol 2020; 17: 123–4. https://doi.org/10.2217/fon-2020-0764
Illiano P, Brambilla R, Parolini C. The mutual interplay of gut microbiota, diet and human disease. FEBS J 2020; 287: 1–55. https://doi.org/10.1111/febs.15217
Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med 2016; 8: 1–11. https://doi.org/10.1186/s13073-016-0307-y
Bashiardes S, Godneva A, Elinav E, et al. Towards utilization of the human genome and microbiome for personalized nutrition. Curr Opin Biotechnol 2018; 51: 57–63. https://doi.org/10.1016/j.copbio.2017.11.013
Barratt MJ, Lebrilla C, Shapiro H-Y, et al. The gut microbiota, food science, and human nutrition: a timely marriage. Cell Host Microbe 2017; 22: 134–41. https://doi.org/10.1016/j.chom.2017.07.006
##submission.downloads##
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2023 Експериментальна онкологія
Ця робота ліцензується відповідно до Creative Commons Attribution-NonCommercial 4.0 International License.
